Lonza expands to produce 30 billion capsules worldwide

SourceGSA Business Report
Date Published02/02/2021
Author NameMolly Hulsey
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Lonza Biologics Inc
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):30
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2026
Domestically, the work will be done:In-house
Capital investment ($):$53.7
Country(ies) from which reshored:Switzerland
City reshored to:Greenwood County
State(s) reshored to:SC
If relevant, work nearshored to:-
Product(s) reshoredtwo-part gelatin capsules
What domestic positive factors made reshoring more attractive?Under-utilized capacity, covid-19
Find Reshoring Articles